SCHEMBL5570287

SCHEMBL5570287

CCc1cc2c(F)c(Oc3ncnc4cc(OCCCN5CCN(CC(F)(F)F)CC5)c(OC)cc34)ccc2[nH]1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 14/20 0.69
▸ FLT4 P35916 9/20 0.69
▸ FLT1 P17948 6/20 0.69
▸ PDGFRB P09619 4/20 0.69
▸ TEK Q02763 4/20 0.69
▸ AURKB Q96GD4 4/20 0.69
▸ RET P07949 2/20 0.69
▸ PLK4 O00444 1/20 0.69
▸ GAK O14976 1/20 0.69
▸ EPHB6 O15197 1/20 0.69
▸ RIPK2 O43353 1/20 0.69
▸ ERN1 O75460 1/20 0.69
▸ STK10 O94804 1/20 0.69
▸ MAP4K4 O95819 1/20 0.69
▸ CHEK2 O96017 1/20 0.69
▸ ABL1 P00519 1/20 0.69
▸ EGFR P00533 1/20 0.69
▸ ERBB2 P04626 1/20 0.69
▸ LCK P06239 1/20 0.69
▸ FYN P06241 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1401636 0.91 KDR (0.84) KDRFLT4FLT1PDGFRBTEK
SCHEMBL12809406 0.87 KDR (0.77) KDRFLT4FLT1PDGFRBTEK
SCHEMBL13471998 0.83 KDR (0.89) KDRFLT4FLT1PDGFRBTEK
SCHEMBL1401668 0.83 KDR (0.89) KDRFLT4FLT1PDGFRBTEK
SCHEMBL3198096 0.83 KDR (0.89) KDRFLT4FLT1PDGFRBTEK
SCHEMBL5566103 0.82 KDR (0.69) KDRFLT4FLT1PDGFRBTEK
Cediranib SCHEMBL29368143 0.82 KDR (1.00) KDRFLT4FLT1PDGFRBTEK
Cediranib SCHEMBL63147 0.82 KDR (1.00) KDRFLT4FLT1PDGFRBTEK
Cediranib SCHEMBL29351458 0.82 KDR (1.00) KDRFLT4FLT1PDGFRBTEK
Cediranib SCHEMBL29383181 0.82 KDR (1.00) KDRFLT4FLT1PDGFRBTEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268230-B2 Quinazoline compounds ASTRAZENECA AB (SE) 2007-09-11 — — US disclosed
Send feedback